Stems Cells and Immunity

Since the early days of modern medicine it has been known that transplantation of tissues from one individual to other results in immune rejection, except when performed between identical twins. Extensive research done in the past decades has uncovered that differences in protein sequences between individuals are the primary targets for the immune response against allogeneic (genetically non-identical) grafts. These molecules were subsequently defined as histocompatibility antigens as they determine whether implanted cells are accepted or rejected by the immune system. Today, the risk of organ rejection remains high despite efforts to match haplotypes of histocompatibility antigens as well as use of immunosuppressive therapies.

Human embryonic stem cells (hESCs) can be propagated in high numbers in vitro, and have the potential to differentiate into a myriad of cell the application of these cells for organ restoration is of particular importance due to limited availability of donated organs. However, it is unclear whether differentiated hESCs will be recognized by the immune system following implantation in humans. Therefore it is imperative to investigate the immune response against differentiated hESCs for successful clinical translation.

The purpose of this review is to describe the current knowledge of antigenicity and immunogenicity of hESCs and their derivatives. While antigenicity refers only to the capacity of cells to express histocompatibility antigens, immunogenicity is a broader term for the potential to elicit immune response through additional factors, such as co-stimulatory molecules. This review summarizes our current view of the histocompatibility antigens and immunomodulating molecules that are expressed on undifferentiated and differentiated hESCs (u/dhESCs). In addition, adaptive and innate immune processes that may develop against the cells following recognition of histocompatibility antigens will be discussed. As rejection processes could severely limit the use of hESC-derived transplants, multiple approaches are being developed to alleviate these risks. I will focus on techniques for derivation of isogenic (genetically identical) hESC lines and discuss the immunological benefits and remaining challenges for their potential application.

·               Expression of histocompatibility antigens on u/dhESCs

·               Expression of T-cell regulating signals in u/dhESCs

·               T-cell response against u/dhESCs measured by functional assays

·               Generation of patient-specific isogenic hESC lines

·               Evidence that malignant progenitor cells

·               Donor natural killer (NK) cells as mediators

·               Antigen processing and presentation

·               Nucleic Acid Sensing Pathways

  • Donor Natural Killer (NK) Cells
  • Immunogenetics

Related Conference of Stems Cells and Immunity

March 19-20, 2018

International Meeting on Nutraceuticals

Singapore
March 26-27, 2018

World Congress on Herbal and Chinese Medicine

Bali, Indonesia
April 20-21, 2018

4th International Conference on Antibiotics: R&D, B2B

Las Vegas, Nevada, USA
April 26-27, 2018

11th European Biosimilars Congress

Rome, Italy
May 07-09, 2018

15th Annual European Pharma Congress

Frankfurt, Germany
June 18-20, 2018

International Conference on Pharmacology

Tokyo, Japan
June 18-20, 2018

International Conference on Pharmacology

Tokyo, Japan
June 20-22, 2018

7th World Congress on Mass Spectrometry

Rome, Italy
June 27-28, 2018

International Conference on Pharmaceutical Analysis and Quality Control Strategies

Vancouver, British Columbia, Canada
July 16-17, 2018

12th Global
Pharmacovigilance & Clinical Trials Summit

Sydney, Australia
July 18-20, 2018

15th Asia-Pacific Pharma Congress

Melbourne, Australia
Jul 30-Aug 01, 2018

10th World Congress on Pharmacology

Barcelona, Spain
July 31-August 01, 2017

Analytical and Bio-Analytical Techniques Congress

Melbourne, Australia
August 15-17, 2018

14th World Congress on Pharmacology and Drug Safety

Stockholm, Sweden
August 20-21, 2018

World Biosimilars Conference

Chicago, USA
September 03-05, 2018

International Conference onClinical Pharmacy

Zurich, Switzerland
September 13-14, 2018

8th World Congress on Chromatography

Prague, Czech Republic
September 14-15, 2018

Annual Neurochemistry and Neuropharmacology Congress

Richmond, Virginia, USA
September 24-25, 2018

12th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Chicago, Illinois, USA
September 17-18, 2018

5th International Conference on Clinical Pharmacy and Pharmacy Practice

San Antonio, Texas, USA
September 17-18, 2018 | San Antonio, Texas, USA

11th World Congress on Pharmacology & Therapeutics

September 17-18, 2018

Annual Pharmacy and Pharmaceutical Science Conference

Kuala Lumpur, Malaysia
September 17-18, 2018

15th International Conference on Pharmaceutical Formulations & Drug Delivery

| Philadelphia, Pennsylvania, USA
September 17-18, 2018

Drug formulation Congress 2018

Singapore
September 20-22, 2018

17th Annual Congress on Pharmaceutics & Drug Delivery Systems

Prague, Czech Republic
September 24-25, 2018

World Congress on Traditional and Complementary Medicine

Abu Dhabi, UAE
September 24-26, 2018

7th International Conference on Clinical Trials

| Chicago, Illinois, USA
(10 Plenary Forums - 1 Event)
September 24-26, 2018

International Conference on Case Reports

Toronto, Canada
September 26-27, 2018

Annual Pharma Pricing & Marketing Congress

Dubai, UAE
September 28-29, 2018

11th World Congress on Pharmaceutical Sciences

| Montreal, Canada
October 01-03, 2018

Global Medicinal Chemistry & GPCR Summit

Las Vegas, USA
August 24-25, 2018

7th Global Advances in Mass Spectrometry

Singapore
October 24-25, 2018

13th International Conference on Biopharma and Biotherapeutics

Boston, Massachusetts, USA
Oct 25-26, 2018

18th Global Dermatology Congress

Budapest, Hungary
Oct 31- Nov 01, 2018

34th International Conference on Pharmaceuticals & Nutraceuticals

San Francisco, California, USA
November 08-09, 2018

18th Annual Pharma Middle East Congress

Abu Dhabi, UAE
November 15-16, 2018

9th Global Experts Meeting on Neuropharmacology

Frankfurt, Germany

Stems Cells and Immunity Conference Speakers